WallStreetZenWallStreetZen

NASDAQ: APGE
Apogee Therapeutics Inc Stock Ownership - Who owns Apogee Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Apogee Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fairmount Funds Management LLCDirector2026-08-0710,370$43.85
$454.72kBuy
Fairmount Funds Management LLCDirector2026-08-0731,838$17.00
$541.25kBuy
Carl DambkowskiMed2026-08-054,125$22.86
$94.30kBuy
Carl DambkowskiMed2026-08-055,500$134.17
$737.93kSell
Michael Thomas HendersonChief Executive Officer2026-07-0820,000$133.63
$2.67MSell
Carl DambkowskiChief Medical Officer2026-07-015,500$132.74
$730.07kSell
Carl DambkowskiChief Medical Officer2026-07-014,125$22.86
$94.30kBuy
Michael Thomas HendersonChief Executive Officer2026-06-2280,000$132.54
$10.60MSell
Carl DambkowskiChief Medical Officer2026-06-2226,400$132.60
$3.50MSell
Michael Thomas HendersonChief Executive Officer2026-06-102,305$86.27
$198.85kSell

1 of 10

APGE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APGE insiders and whales buy or sell their stock.

APGE Shareholders

What type of owners hold Apogee Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Nimish P. Shah2.31%1,750,000$236.39MInsider
Michael Thomas Henderson1.22%920,941$124.40MInsider
Fairmount Funds Management LLC1.12%844,166$114.03MInsider
Carl Dambkowski0.22%168,498$22.76MInsider
Jane Henderson0.21%158,371$21.39MInsider
Jennifer A. Fox0.05%34,824$4.70MInsider
William A. Jones Jr.0.05%34,824$4.70MInsider
Mark C. McKenna0.03%20,000$2.70MInsider
Venrock Adviser LLC0.01%8,493$1.15MInstitution
Venroc0.01%8,493$1.15MInstitution

1 of 3

APGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APGE0.09%5.19%Net SellingNet Selling
IONS0.11%3.34%Net SellingNet Selling
CYTK0.12%11.03%Net SellingNet Selling
KYMR0.12%31.95%Net SellingNet Selling
PRAX0.12%50.28%Net SellingNet Buying
View Top Biotech Stocks

Apogee Therapeutics Stock Ownership FAQ

Who owns Apogee Therapeutics?

Apogee Therapeutics (NASDAQ: APGE) is owned by 0.09% institutional shareholders, 5.19% Apogee Therapeutics insiders, and 94.72% retail investors. Nimish P. Shah is the largest individual Apogee Therapeutics shareholder, owning 1.75M shares representing 2.31% of the company. Nimish P. Shah's Apogee Therapeutics shares are currently valued at $236.39M.

If you're new to stock investing, here's how to buy Apogee Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.